737.54
Schlusskurs vom Vortag:
$762.50
Offen:
$760.75
24-Stunden-Volumen:
15.90M
Relative Volume:
1.00
Marktkapitalisierung:
$1.88T
Einnahmen:
$214.96B
Nettoeinkommen (Verlust:
$70.59B
KGV:
26.81
EPS:
27.5066
Netto-Cashflow:
$48.25B
1W Leistung:
+2.25%
1M Leistung:
+10.81%
6M Leistung:
+11.33%
1J Leistung:
+4.08%
Meta Platforms Inc Stock (META) Company Profile
Firmenname
Meta Platforms Inc
Sektor
Telefon
650-543-4800
Adresse
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, RDDT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
META
Meta Platforms Inc
|
737.54 | 1.88T | 214.96B | 70.59B | 48.25B | 27.51 |
|
GOOGL
Alphabet Inc
|
347.64 | 4.25T | 446.32B | 244.21B | 53.27B | 19.91 |
|
GOOG
Alphabet Inc
|
343.65 | 4.20T | 446.32B | 244.21B | 53.27B | 19.91 |
|
SPOT
Spotify Technology Sa
|
523.96 | 107.72B | 20.32B | 3.16B | 3.82B | 12.55 |
|
RDDT
Reddit Inc
|
148.60 | 28.59B | 2.47B | 707.54M | 868.73M | 3.5267 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-28 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-09-25 | Bestätigt | Canaccord Genuity | Buy |
| 2026-09-25 | Bestätigt | Deutsche Bank | Buy |
| 2026-09-25 | Bestätigt | Piper Sandler | Overweight |
| 2026-09-25 | Bestätigt | TD Cowen | Buy |
| 2026-09-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-09-21 | Bestätigt | Wells Fargo | Overweight |
| 2026-09-10 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2026-08-27 | Bestätigt | Rosenblatt | Buy |
| 2026-08-27 | Bestätigt | Truist | Buy |
| 2026-07-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-07-16 | Fortgesetzt | Wedbush | Neutral |
| 2026-07-10 | Bestätigt | Citizens | Mkt Outperform |
| 2026-07-07 | Hochstufung | Erste Group | Hold → Buy |
| 2026-06-02 | Hochstufung | Arete | Neutral → Buy |
| 2026-05-20 | Bestätigt | Wells Fargo | Overweight |
| 2026-05-05 | Bestätigt | Mizuho | Outperform |
| 2026-04-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2026-04-10 | Bestätigt | Wolfe Research | Outperform |
| 2026-04-09 | Bestätigt | Rosenblatt | Buy |
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-03-30 | Bestätigt | Morgan Stanley | Overweight |
| 2026-03-05 | Herabstufung | Arete | Buy → Neutral |
| 2026-03-05 | Hochstufung | Erste Group | Hold → Buy |
| 2026-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Canaccord Genuity | Buy |
| 2026-01-29 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-29 | Bestätigt | Deutsche Bank | Buy |
| 2026-01-29 | Bestätigt | Evercore ISI | Outperform |
| 2026-01-29 | Bestätigt | Guggenheim | Buy |
| 2026-01-29 | Bestätigt | JP Morgan | Overweight |
| 2026-01-29 | Bestätigt | Jefferies | Buy |
| 2026-01-29 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Bestätigt | Mizuho | Outperform |
| 2026-01-29 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-01-29 | Bestätigt | Morgan Stanley | Overweight |
| 2026-01-29 | Bestätigt | Piper Sandler | Overweight |
| 2026-01-29 | Bestätigt | Pivotal Research Group | Buy |
| 2026-01-29 | Bestätigt | Robert W. Baird | Outperform |
| 2026-01-29 | Bestätigt | Roth Capital | Buy |
| 2026-01-29 | Bestätigt | Stifel | Buy |
| 2026-01-29 | Bestätigt | UBS | Buy |
| 2026-01-29 | Bestätigt | Wedbush | Outperform |
| 2026-01-29 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Wolfe Research | Outperform |
| 2026-01-26 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | Bestätigt | Raymond James | Strong Buy |
| 2026-01-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | Bestätigt | Stifel | Buy |
| 2026-01-13 | Bestätigt | TD Cowen | Buy |
| 2026-01-12 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-08 | Bestätigt | Guggenheim | Buy |
| 2025-12-04 | Hochstufung | Arete | Neutral → Buy |
| 2025-11-24 | Eingeleitet | BNP Paribas Exane | Outperform |
| 2025-11-10 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-30 | Bestätigt | Barclays | Overweight |
| 2025-10-30 | Bestätigt | Bernstein | Outperform |
| 2025-10-30 | Bestätigt | BofA Securities | Buy |
| 2025-10-30 | Bestätigt | Citigroup | Buy |
| 2025-10-30 | Bestätigt | JP Morgan | Overweight |
| 2025-10-30 | Bestätigt | Jefferies | Buy |
| 2025-10-30 | Bestätigt | Mizuho | Outperform |
| 2025-10-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-10-30 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-10-30 | Bestätigt | Piper Sandler | Overweight |
| 2025-10-30 | Bestätigt | Stifel | Buy |
| 2025-10-30 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2025-10-20 | Bestätigt | Oppenheimer | Outperform |
| 2025-10-07 | Bestätigt | Wells Fargo | Overweight |
| 2025-09-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-31 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-07-31 | Bestätigt | Bernstein | Outperform |
| 2025-07-31 | Bestätigt | BofA Securities | Buy |
| 2025-07-31 | Bestätigt | Citigroup | Buy |
| 2025-07-31 | Bestätigt | Citizens JMP | Mkt Outperform |
| 2025-07-31 | Bestätigt | JP Morgan | Overweight |
| 2025-07-31 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-07-31 | Bestätigt | Morgan Stanley | Overweight |
| 2025-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2025-07-31 | Bestätigt | Pivotal Research Group | Buy |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-31 | Bestätigt | UBS | Buy |
| 2025-07-31 | Bestätigt | Wedbush | Outperform |
| 2025-07-31 | Bestätigt | Wells Fargo | Overweight |
| 2025-07-28 | Bestätigt | Guggenheim | Buy |
| 2025-07-16 | Bestätigt | Canaccord Genuity | Buy |
| 2025-07-03 | Hochstufung | Needham | Underperform → Hold |
| 2025-06-26 | Bestätigt | UBS | Buy |
| 2025-06-24 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | BofA Securities | Buy |
| 2025-05-01 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | Evercore ISI | Outperform |
| 2025-05-01 | Bestätigt | Goldman | Buy |
| 2025-05-01 | Bestätigt | Guggenheim | Buy |
| 2025-05-01 | Bestätigt | JP Morgan | Overweight |
| 2025-05-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | Bestätigt | MoffettNathanson | Buy |
| 2025-05-01 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-05-01 | Bestätigt | Morgan Stanley | Overweight |
| 2025-05-01 | Bestätigt | Oppenheimer | Outperform |
| 2025-05-01 | Bestätigt | Piper Sandler | Overweight |
| 2025-05-01 | Bestätigt | Pivotal Research Group | Buy |
| 2025-05-01 | Bestätigt | Raymond James | Strong Buy |
| 2025-05-01 | Bestätigt | Rosenblatt | Buy |
| 2025-05-01 | Bestätigt | Roth Capital | Buy |
| 2025-05-01 | Bestätigt | Stifel | Buy |
| 2025-05-01 | Bestätigt | Truist | Buy |
| 2025-05-01 | Bestätigt | UBS | Buy |
| 2025-05-01 | Bestätigt | Wedbush | Outperform |
| 2025-04-14 | Bestätigt | Citigroup | Buy |
| 2025-04-10 | Bestätigt | Piper Sandler | Overweight |
| 2025-01-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2025-01-23 | Bestätigt | BofA Securities | Buy |
| 2025-01-22 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Bestätigt | Jefferies | Buy |
| 2025-01-03 | Bestätigt | Wolfe Research | Outperform |
| 2024-10-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-10-31 | Bestätigt | Pivotal Research Group | Buy |
| 2024-10-11 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-09 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2024-10-01 | Eingeleitet | Pivotal Research Group | Buy |
| 2024-09-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-09-10 | Eingeleitet | DA Davidson | Buy |
| 2024-09-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-01 | Bestätigt | BofA Securities | Buy |
| 2024-07-19 | Bestätigt | Oppenheimer | Outperform |
| 2024-07-16 | Eingeleitet | Wolfe Research | Outperform |
| 2024-07-10 | Bestätigt | TD Cowen | Buy |
| 2024-07-08 | Bestätigt | Wells Fargo | Overweight |
| 2024-07-01 | Bestätigt | Raymond James | Strong Buy |
| 2024-06-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-05-02 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2024-04-25 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-15 | Bestätigt | Citigroup | Buy |
| 2024-04-11 | Bestätigt | Piper Sandler | Overweight |
| 2024-04-08 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-04 | Bestätigt | Jefferies | Buy |
| 2024-02-02 | Bestätigt | Guggenheim | Buy |
| 2024-02-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2024-02-02 | Bestätigt | JP Morgan | Overweight |
| 2024-02-02 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | Bestätigt | Mizuho | Buy |
| 2024-02-02 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Bestätigt | Morgan Stanley | Overweight |
| 2024-02-02 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-02 | Bestätigt | Piper Sandler | Overweight |
| 2024-02-02 | Bestätigt | ROTH MKM | Buy |
| 2024-02-02 | Bestätigt | Raymond James | Strong Buy |
| 2024-02-02 | Bestätigt | Robert W. Baird | Outperform |
| 2024-02-02 | Bestätigt | Seaport Research Partners | Buy |
| 2024-02-02 | Bestätigt | Stifel | Buy |
| 2024-02-02 | Bestätigt | Susquehanna | Positive |
| 2024-02-02 | Bestätigt | TD Cowen | Outperform |
| 2024-02-02 | Bestätigt | UBS | Buy |
| 2024-02-02 | Bestätigt | Wedbush | Outperform |
| 2024-02-02 | Bestätigt | Wells Fargo | Overweight |
| 2024-02-02 | Bestätigt | Wolfe Research | Outperform |
| 2024-01-23 | Bestätigt | Citigroup | Buy |
| 2024-01-17 | Bestätigt | Piper Sandler | Overweight |
| 2024-01-17 | Bestätigt | Wells Fargo | Overweight |
| 2024-01-09 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2023-12-20 | Fortgesetzt | Raymond James | Strong Buy |
| 2023-10-24 | Eingeleitet | Seaport Research Partners | Buy |
| 2023-08-22 | Eingeleitet | Wedbush | Outperform |
| 2023-08-01 | Bestätigt | Argus | Buy |
| 2023-07-28 | Hochstufung | China Renaissance | Hold → Buy |
| 2023-07-27 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-07-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | Bestätigt | Mizuho | Buy |
| 2023-07-25 | Hochstufung | New Street | Neutral → Buy |
| 2023-07-19 | Bestätigt | Jefferies | Buy |
| 2023-07-19 | Bestätigt | Truist | Buy |
| 2023-07-17 | Bestätigt | Credit Suisse | Outperform |
| 2023-07-17 | Bestätigt | Goldman | Buy |
| 2023-07-17 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-07-13 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | Bestätigt | Deutsche Bank | Buy |
| 2023-06-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-05-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2023-04-27 | Bestätigt | Credit Suisse | Outperform |
| 2023-04-27 | Bestätigt | Deutsche Bank | Buy |
| 2023-04-27 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-27 | Bestätigt | Goldman | Buy |
| 2023-04-27 | Bestätigt | Guggenheim | Buy |
| 2023-04-27 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-04-27 | Bestätigt | JP Morgan | Overweight |
| 2023-04-27 | Bestätigt | Mizuho | Buy |
| 2023-04-27 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2023-04-27 | Bestätigt | Morgan Stanley | Overweight |
| 2023-04-27 | Bestätigt | Oppenheimer | Outperform |
| 2023-04-27 | Bestätigt | Piper Sandler | Overweight |
| 2023-04-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-27 | Bestätigt | Raymond James | Outperform |
| 2023-04-27 | Bestätigt | Robert W. Baird | Outperform |
| 2023-04-27 | Bestätigt | Rosenblatt | Buy |
| 2023-04-27 | Bestätigt | Stifel | Buy |
| 2023-04-27 | Bestätigt | TD Cowen | Market Perform |
| 2023-04-27 | Bestätigt | Truist | Buy |
| 2023-04-27 | Bestätigt | Wolfe Research | Outperform |
Alle ansehen
Meta Platforms Inc Aktie (META) Neueste Nachrichten
Musings About the Agentic Future - The Motley Fool
Should You Buy Alphabet Before Oct. 28? - The Motley Fool
Zacks Investment Ideas feature highlights: Meta Platform, Micron, SK Hynix, SanDisk and and ASML - Zacks Investment Research
Prediction: $5,000 Invested in Taiwan Semiconductor Could Be Worth This Much by 2030 - The Motley Fool
Alphabet vs. Meta Platforms: Here's What Revenue Trends Tell Investors About These Media Giants Turned Artificial Intelligence Companies - The Motley Fool
Why the Market Dipped But Meta Platforms (META) Gained Today - Zacks Investment Research
Bull Market Just Completed Year 4. Will It Finish Year 5? Here's What History Says. - The Motley Fool
Bearish AI Headlines: An Artificial Wave of Panic - Zacks Investment Research
Is Meta Platforms Stock Heading for $1,000? - The Motley Fool
Is Oklo Stock Your Ticket to Becoming a Millionaire? - The Motley Fool
AppLovin vs. Reddit: Which Technology Stock Is a Better Buy in 2026? - The Motley Fool
Meta Platforms Rises 12% in 3 Months: Buy, Sell, or Hold the Stock? - Zacks Investment Research
Meta Platforms, Inc. (META) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research
Broadcom vs. Nvidia: The AI Revolution Is Big Enough for Both. Here's the Better Buy. - The Motley Fool
APAC Sustainable Data Center Market Size & ShareIndustry Outlook and Forecast 2026-2031 | AI and Renewable Energy Investments Propel Market to USD 57.18 Billion - GlobeNewswire Inc.
President Donald Trump's Investment Team Dumped AMD in August and Bought Up to $25 Million in One of the Cheapest "Magnificent Seven" Stocks - The Motley Fool
Alphabet vs. Meta Platforms: Which Stock Is a Better Buy in 2026? - The Motley Fool
Broadcom vs. Qualcomm: Which Chip Stock Is a Better Buy in 2026? - The Motley Fool
Stock Market Today, Oct. 12: Dow Gains as Memory Stocks Weigh on Nasdaq - The Motley Fool
Afraid of a Stock Market Crash? 4 Great ETFs to Buy Regardless. - The Motley Fool
Why Meta Platforms Stock Rallied Monday Morning - The Motley Fool
Top Stock Picks for Week of October 12, 2026 - Zacks Investment Research
Jamie Dimon Sharpened His Warning About a Looming Corporate Credit Squeeze, Saying Global Competition for Capital Means "The Market Will Ask for More." Here's Why That Warning Matters for Borrowers and Bond Investors. - The Motley Fool
3 Dividend Stocks Riding the Same Nuclear Build-Out From Different Angles - The Motley Fool
Guide to Magnificent Seven ETF investing - Zacks Investment Research
Nvidia and Micron Technology Just Received Some Very Bad News From an Unlikely Place - The Motley Fool
History Says This Will Happen to AMD Stock in 2027 - The Motley Fool
Prediction: Meta Platforms Stock Will Drop After Earnings, and That Could Be an Incredible Buying Opportunity - The Motley Fool
Billionaire Ray Dalio Said The AI Bubble Is Close To Popping. Could SpaceX Be the Culpirit? - The Motley Fool
Schwab's Dividend ETF's Worst Year Since 2012 Was a 5.5% Loss. The Cost Showed Up in the Good Years. - The Motley Fool
Where Will Credo Technology Be in 3 Years? - The Motley Fool
Like Meta's Muse AI Agents? 4 AI Semiconductor Stocks Set to Benefit From the Rise of AI Agents. - The Motley Fool
Broadcom vs. Intel: Which Chip Stock Is a Better Buy in 2026? - The Motley Fool
Here's What a $10,000 Investment in Broadcom Stock Could Be Worth in 5 Years. (Hint: It Could Be 1 of the Best AI Stocks to Buy Today.) - The Motley Fool
Sundar Pichai Reported Alphabet's Cloud Revenue Grew 82% to $24.8 Billion Last Quarter, With the Gemini App Reaching 950 Million Monthly Users. Is Google Cloud Becoming a Bigger Growth Driver Than Search? - The Motley Fool
Hims & Hers Health (NYSE: HIMS) Faces Securities Fraud Class Action After FTC Lawsuit Reveal Drives Stock Sharply LowerHBSS - GlobeNewswire Inc.
Fastly: Riding the Agentic AI Wave - Zacks Investment Research
Nvidia and AMD Lead the AI Market. 1 Chip Stock Has Far Greater Upside. - The Motley Fool
$5,000 Invested in Nvidia 5 Years Ago Would Be Worth $58,045 Today. Here’s How Much a $5,000 Investment Today Could Be Worth by 2031 - The Motley Fool
Navigating the AI Boom: Bubble is NOT a Four-Letter Word - Zacks Investment Research
Buy Cisco Systems as Leader of the AI Cloud Networking Space for 2027 - Zacks Investment Research
How to Play AI Theme With ETFs Amid Overvaluation Concerns? - Zacks Investment Research
Guide to Magnificent Seven ETF investing - Zacks Investment Research
Should You Forget Nvidia and Buy These 2 Artificial Intelligence (AI) Chip Stocks Instead? - The Motley Fool
Better Cloud AI Pick: CoreWeave or Nebius Group? - The Motley Fool
Meet the Super Semiconductor Stock Crushing Nvidia in 2026 - The Motley Fool
ETFs to Benefit as Nasdaq's Breakthrough Still Matters - Zacks Investment Research
Big Tech Keeps Signing Nuclear Deals With the Same Company. Here's Who It Is and Why That Matters More Than Any Single Deal. - The Motley Fool
Meta (META) COO sells 1,575 shares at $728.08 each under a preset trading plan. - Stock Titan
Why Meta Platforms (META) Dipped More Than Broader Market Today - Zacks Investment Research
Finanzdaten der Meta Platforms Inc-Aktie (META)
Umsatz
Nettogewinn
Free Cashflow
ENV
Meta Platforms Inc-Aktie (META) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Olivan Javier | Chief Operating Officer |
Oct 05 '26 |
Sale |
728.08 |
946 |
688,764 |
7,878 |
| Olivan Javier | Chief Operating Officer |
Oct 05 '26 |
Sale |
728.08 |
629 |
457,962 |
1,061 |
| Olivan Javier | Officer |
Oct 05 '26 |
Proposed Sale |
728.08 |
1,575 |
1,146,726 |
0 |
| Olivan Javier | Officer |
Sep 28 '26 |
Proposed Sale |
749.82 |
1,575 |
1,180,966 |
0 |
| Olivan Javier | Chief Operating Officer |
Sep 28 '26 |
Sale |
750.42 |
946 |
709,902 |
8,824 |
| Olivan Javier | Chief Operating Officer |
Sep 28 '26 |
Sale |
748.91 |
629 |
471,064 |
1,118 |
| Zuckerberg Mark | Officer |
Sep 24 '26 |
Proposed Sale |
777.44 |
27,474 |
21,359,454 |
0 |
| Zuckerberg Mark | COB and CEO |
Sep 24 '26 |
Sale |
777.44 |
27,474 |
21,359,454 |
0 |
| Olivan Javier | Chief Operating Officer |
Sep 21 '26 |
Sale |
680.27 |
946 |
643,535 |
9,770 |
| Olivan Javier | Officer |
Sep 21 '26 |
Proposed Sale |
680.27 |
1,575 |
1,071,425 |
0 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):